Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
ABSTRACT Ebola virus (EBOV) infection is a major public health concern due to high fatality rates and limited effective treatments. Statins, widely used cholesterol-lowering drugs, have pleiotropic mechanisms of action and were suggested as potential adjunct therapy for Ebola virus disease (EVD) dur...
Guardado en:
Autores principales: | Punya Shrivastava-Ranjan, Mike Flint, Éric Bergeron, Anita K. McElroy, Payel Chatterjee, César G. Albariño, Stuart T. Nichol, Christina F. Spiropoulou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb5a3a1b6f3145578abdd9b3d291c4b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ebola virus disease: Essential clinical knowledge
por: Mahmoud Tawfik Khalafallah, et al.
Publicado: (2017) -
Ébola: caracterización, historia y manifestaciones cutáneas; lo que debemos saber
por: Kolbach,Marianne, et al.
Publicado: (2015) -
Natural History of Aerosol-Induced Ebola Virus Disease in Rhesus Macaques
por: Isaac Downs, et al.
Publicado: (2021) -
Rousette Bat Dendritic Cells Overcome Marburg Virus-Mediated Antiviral Responses by Upregulation of Interferon-Related Genes While Downregulating Proinflammatory Disease Mediators
por: Joseph Prescott, et al.
Publicado: (2019) -
The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge
por: Patrick Younan, et al.
Publicado: (2017)